Net profit of Glaxosmithkline Pharmaceuticals rose 402.80% to Rs 229.88 crore in the quarter ended December 2024 as against Rs 45.72 crore during the previous quarter ended December 2023. Sales rose 17.90% to Rs 949.42 crore in the quarter ended December 2024 as against Rs 805.26 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 949.42 | 805.26 | 18 |
OPM % | 30.75 | 27.08 | - |
PBDT | 326.90 | 245.85 | 33 |
PBT | 308.10 | 228.74 | 35 |
NP | 229.88 | 45.72 | 403 |